Key Metrics

Market Cap	1.05B
Total Shares Outstanding	40.49M
Book Value	6.96
PE Ratio	-

PS Ratio	7.48
PB Ratio	3.72
Forward PE Ratio	116.28
ROIC	-

Return on Aseets	-9.19
Return on Equity	-12.43
Dividend	-
Dividend Yield	-

Balancesheet Metrics

Total Assets	318.56M
Total Liability	37.33M
Assets-to-Libability Ratio	8.53

Total Current Assets	293.82M
Total Current Liability	25.88M
Current Ratio	11.36

Quick Ratio	10.5
Debt to Equity Ratio	-

Income Statement Metrics

Net Income	-48.69M
EPS	-0.71
EBITA	-45.00M

Gross Profit	4.52M
Gross Profit Margin	-19.62%
Operating Margin	-21.46%

Net Profit Margin

-215.5%

Price Metrics

5 Days MA	25.47
10 Days MA	25.84
20 Days MA	27.68
50 Days MA	30.76
200 Days MA	45.01

52 Weeks High	66.54
52 Weeks low	24.64
All Time High	66.54

RSI	33.52
MACD	-

Share Stats

Shares Float
Shares Short

% Short
% Insider

% Institutions

% Institutions

News

Profile

Rxsight Inc (RXST)

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Exchange: NASDAQ

IPO Date: 7/30/2021

Sector: Healthcare

Industry: Medical Devices

Employees: 498

Address: 100 Columbia, Aliso Viejo, CA, United States, 92656

https://www.rxsight.com

Quarterly Yearly

&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;	12/31/2024	09/30/2024	06/30/2024	03/31/2024	12/31/2023	09/30/2023	06/30/2023	03/31/2023	12/31/2022	09/30/2022	Totals
	12/31/2024	09/30/2024	06/30/2024	03/31/2024	12/31/2023	09/30/2023	06/30/2023	03/31/2023	12/31/2022	09/30/2022	Totals
Assets	318.56K	310.47K	305.50K	183.16K	182.55K	181.85K	195.26K	202.53K	150.16K	155.71K	3.22M
Current Assets	293.82K	286.77K	281.22K	168.56K	168.41K	167.95K	180.44K	187.67K	134.56K	139.16K	2.92M
Cash And Short Term Investments	237.22K	237.12K	233.28K	125.35K	127.18K	131.88K	147.09K	153.94K	105.80K	112.83K	2.34M
Net Receivables	30.05K	25.37K	25.72K	21.55K	20.28K	15.24K	13.29K	12.67K	10.96K	9.02K	214.95K
Inventory	22.01K	21.67K	19.44K	18.70K	17.42K	18.92K	17.95K	18.07K	14.84K	15.34K	248.53K
Other Current Assets	4.54K	2.61K	2.77K	2.96K	3.52K	1.90K	2.11K	2.99K	2.96K	1.97K	45.44K
Non Current Assets	24.74K	23.70K	24.28K	14.61K	14.14K	13.90K	14.82K	14.87K	15.61K	16.54K	300.69K
Property Plant Equipment	-	-	-	-	-	-	13.71K	9.80K	10.14K	10.62K	124.74K
Long Term Investments	-	-	-	-	-	-	-	-	-	-	-
Non Currrent Assets Other	1.11K	924	303	226	147	137	348	746	1.53K	1.59K	18.57K
Liabilities	37.33K	33.21K	30.29K	19.24K	22.19K	20.37K	38.07K	57.52K	60.26K	59.75K	1.45M
Current Liabilities	25.88K	22.64K	19.62K	18.33K	20.90K	18.94K	16.57K	14.88K	17.24K	16.37K	264.82K
Accounts Payable	4.54K	4.58K	5.09K	5.06K	3.86K	4.11K	4.00K	3.72K	2.60K	4.17K	61.09K
Short Long Term Debt	-	-	-	-	-	-	-	-	-	-	-
Other Current Liabilities	17.25K	18.06K	13.05K	10.04K	13.19K	12.86K	10.59K	9.18K	11.32K	10.25K	165.44K
Non Current Liabilities	11.45K	10.57K	10.67K	908	1.28K	1.43K	21.51K	42.65K	43.02K	43.38K	1.18M
Long Term Debt	-	-	-	-	-	-	-	42.65K	-	43.38K	303.95K
Other Liabilities	-	-	-	-	-	-	76	-	-	-	3.90K
Stockholder Equity	281.24K	277.26K	275.21K	163.93K	160.36K	161.48K	157.19K	145.01K	89.90K	95.96K	1.42M
Preferred Stock Equity	-	-	-	-	-	-	-	-	-	-	-
Liabilities And Stockholders Equity	318.56K	310.47K	305.50K	183.16K	182.55K	181.85K	195.26K	202.53K	150.16K	155.71K	3.12M
Common Equity	-	-	-	-	-	-	-	34	28	28	206
Retained Earnings	-	-	-	-	-	-	-	-559.24K	-546.03K	-530.42K	-4.04M
Totals		1.63M	1.59M	1.55M	935.78K	938.00K	932.82K	1.03M	562.20K	275.05K	361.35K	431.61K	490.54K	586.88K	654.82K	-221.14K	889.02K	718.91K	-	-	13.35M

&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	Totals
	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	Totals
Assets	318.56K	182.55K	150.16K	192.72K	100.68K	110.43K	1.06M
Current Assets	293.82K	168.41K	134.56K	176.29K	81.50K	90.20K	944.78K
Cash And Short Term Investments	237.22K	127.18K	105.80K	159.33K	68.97K	80.67K	779.18K
Net Receivables	30.05K	20.28K	10.96K	4.86K	2.87K	789	69.80K
Inventory	22.01K	17.42K	14.84K	8.03K	8.29K	7.22K	77.80K
Other Current Assets	4.54K	3.52K	2.96K	8.14K	1.37K	1.52K	22.06K
Non Current Assets	24.74K	14.14K	15.61K	16.43K	19.18K	20.23K	110.33K
Property Plant Equipment	-	-	10.14K	11.22K	18.61K	19.25K	59.21K
Long Term Investments	-	-	-	-	-	-	-
Non Currrent Assets Other	1.11K	147	767	114	110	983	3.23K
Liabilities	37.33K	22.19K	60.26K	54.48K	398.21K	415.04K	987.50K
Current Liabilities	25.88K	20.90K	17.24K	11.08K	11.60K	8.46K	95.15K
Accounts Payable	4.54K	3.86K	2.60K	1.69K	1.13K	2.20K	16.02K
Short Long Term Debt	-	-	-	-	-	-	-
Other Current Liabilities	17.25K	13.19K	9.35K	5.71K	9.19K	4.89K	59.59K
Non Current Liabilities	11.45K	1.28K	43.02K	43.40K	386.61K	406.59K	892.35K
Long Term Debt	-	-	-	43.40K	-	-	43.40K
Other Liabilities	-	-	-	-	136.89K	189.68K	326.57K
Stockholder Equity	281.24K	160.36K	89.90K	138.24K	-297.53K	-304.61K	67.60K
Preferred Stock Equity	-	-	-	-	-	-	-
Liabilities And Stockholders Equity	318.56K	182.55K	150.16K	192.72K	100.68K	110.43K	1.06M
Common Equity	-	-	28	27	80.78K	56.42K	137.26K
Retained Earnings	-	-	-546.03K	-479.28K	-	-	-1.03M
Totals		1.63M	938.00K	272.32K	588.61K	1.13M	1.22M	5.78M

&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;	06/30/2022	03/31/2022	12/31/2021	09/30/2021	06/30/2021	03/31/2021	12/31/2020	09/30/2020	06/30/2020	03/31/2020	Totals
	06/30/2022	03/31/2022	12/31/2021	09/30/2021	06/30/2021	03/31/2021	12/31/2020	09/30/2020	06/30/2020	03/31/2020	Totals
Revenue	11.36K	8.94K	8.43K	5.79K	4.90K	3.48K	4.91K	4.17K	2.71K	2.89K	57.57K
Cost Of Revenue	6.57K	5.18K	5.56K	4.45K	5.71K	2.37K	3.53K	3.45K	3.18K	2.81K	42.80K
Gross Profit	4.79K	3.76K	2.87K	1.34K	-812	1.12K	1.38K	720	-474	78	14.77K
Operating Expenses	20.58K	20.34K	17.53K	14.45K	13.06K	12.25K	13.21K	9.63K	11.51K	9.47K	142.05K
Selling General Administrative	14.39K	13.62K	11.62K	9.08K	6.50K	5.61K	4.40K	3.83K	3.25K	-	72.29K
Research Development	6.19K	6.72K	5.92K	5.38K	6.56K	6.64K	5.27K	5.80K	5.08K	5.78K	59.34K
Other Operating Expenses	27.15K	25.52K	23.09K	18.90K	-	14.62K	-	13.08K	-	12.29K	134.64K
Operating Income	-15.79K	-16.58K	-14.66K	-13.11K	-13.88K	-11.13K	-8.29K	-8.91K	-8.81K	-9.40K	-120.56K
Net Interest Income	-940	-1.01K	-1.07K	-1.07K	-811	-681	-477	60	143	-	-5.86K
Interest Income	196	46	10	11	15	17	21	63	147	-	526
Interest Expense	1.14K	1.06K	1.08K	1.08K	826	698	498	3	4	5	6.39K
Other Income Expense Net	-940	-1.01K	-1.07K	435	1.21K	4.34K	35.07K	39.58K	-4.18K	-7.10K	66.33K
Income Before Tax	-16.73K	-17.59K	-15.73K	-12.68K	-13.47K	-6.80K	26.30K	30.67K	-12.84K	-16.50K	-55.37K
Tax Provision	-	4	2	-4	3	7	4	8	40	-	64
NetIncome	-16.73K	-17.60K	-15.73K	-12.67K	-13.48K	-6.80K	26.30K	30.66K	-12.88K	-16.50K	-55.44K
NetIncome Applicable To Common Shares	-16.73K	-17.60K	-15.73K	-12.67K	-13.48K	-6.80K	-	5.90K	-16.98K	-20.75K	-114.84K
Ebit	-15.60K	-16.53K	-14.65K	-11.60K	-12.65K	-6.10K	-	30.68K	-8.81K	-16.49K	-71.75K
Basic EPS	-	-0.64	-0.58	-0.68	-0.51	-	-1.7	-	-	-	-4.11
Totals		8.90K	-2.73K	-2.56K	-2.90K	-29.78K	12.83K	112.13K	169.38K	-38.90K	-53.42K	172.94K

&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;	12/31/2021	12/31/2020	12/31/2019	Totals
	12/31/2021	12/31/2020	12/31/2019	Totals
Revenue	22.59K	14.68K	2.24K	39.51K
Cost Of Revenue	18.08K	12.97K	4.06K	35.11K
Gross Profit	4.52K	1.71K	-1.82K	4.40K
Operating Expenses	57.30K	37.11K	44.77K	139.19K
Selling General Administrative	32.80K	15.18K	15.20K	63.18K
Research Development	24.50K	21.93K	29.57K	76.00K
Other Operating Expenses	75.38K	50.08K	48.83K	174.29K
Operating Income	-52.79K	-35.41K	-46.07K	-134.27K
Net Interest Income	-3.63K	33	2.28K	-1.31K
Interest Income	54	543	2.31K	2.90K
Interest Expense	3.68K	510	26	4.22K
Other Income Expense Net	4.11K	63.04K	172.31K	239.47K
Income Before Tax	-48.68K	27.63K	126.24K	105.20K
Tax Provision	8	57	24	89
NetIncome	-48.69K	27.57K	126.22K	105.11K
NetIncome Applicable To Common Shares	-48.69K	3.37K	26.13K	-19.20K
Ebit	-45.00K	28.14K	126.27K	109.41K
Basic EPS	-1.77	-1.7	-	-3.4699999999999998
Totals		-4.45K	269.15K	678.60K	943.30K

&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;	12/31/2024	09/30/2024	06/30/2024	03/31/2024	12/31/2023	09/30/2023	06/30/2023	03/31/2023	12/31/2022	09/30/2022	Totals
	12/31/2024	09/30/2024	06/30/2024	03/31/2024	12/31/2023	09/30/2023	06/30/2023	03/31/2023	12/31/2022	09/30/2022	Totals
Cash From Operating Activities	-4.26K	650	-4.11K	-9.31K	-9.89K	-7.98K	-7.55K	-17.76K	-13.85K	-15.19K	-198.97K
Net Income	-5.94K	-6.34K	-6.08K	-9.10K	-9.18K	-12.41K	-13.80K	-13.21K	-15.61K	-16.82K	-163.93K
Depreciation	523	1.14K	820	1.14K	1.08K	1.13K	1.03K	999	961	980	19.89K
Extraordinary Items	-	-	-	-	-	-	-	-	-	-	-
Change Receivables	-	-	-	-	-	-	-	-1.71K	-1.94K	-2.14K	-7.81K
Change To Inventory	-408	-2.40K	-799	-1.39K	1.35K	-977	117	-3.24K	203	-4.05K	-18.71K
Change To Liabilities	-	-	-	-	-	-	-	-2.33K	730	3.35K	1.61K
Change To Net Income	-	-	-	-	-	-	-	3.31K	3.26K	3.22K	-7.94K
ChangeToOperatingActivities	-	-	-	-	-	-	-	2.81K	-	2.88K	4.98K
Cash flows From Investing Activities	-	-	-	-	-	-	-	-48.37K	10.40K	560	-60.22K
Capital Expenditures	-847	-1.10K	-1.52K	-1.97K	-1.59K	-653	-1.82K	-747	-362	-580	-17.13K
Other Cashflows From Investing Activities	-	-	-	-	-	-	-	-	-	-	-
Cash From Financing Activities	2.98K	878	111.55K	7.99K	5.15K	-8.23K	891	65.31K	6.31K	-455	355.42K
Net Borrowings	-	-	-	-	-	-	-	-20.04K	-1	-2	-5.26K
Sale Purchase Of Stock	-	2.13K	1	-	-2	-1.08K	-	-337	-1.48K	-150	124
Dividends Paid	-	-	-	-	-	1.08K	-	337	-	-	1.42K
Other Cashflows From Financing Activities	-	889	-376	-2.13K	-610	40	17.64K	868	1.49K	-578	142.89K
Cash And Cash Equivalents Changes	-	-	-	-	-	-	-	-824	2.86K	-15.08K	-13.39K
Totals		-7.95K	-4.15K	99.49K	-14.77K	-13.68K	-29.09K	-3.49K	-34.95K	-7.03K	-44.05K	-16.01K	-17.13K	-52.77K	133.38K	15.88K	10.07K	43.49K	-7.51K	-15.76K	-985	32.99K

&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	Totals
	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	Totals
Cash From Operating Activities	-16.95K	-41.59K	-58.85K	-44.71K	-35.20K	-40.62K	-237.92K
Net Income	-27.45K	-48.61K	-66.76K	-48.69K	27.57K	126.22K	-37.71K
Depreciation	3.62K	4.24K	4.02K	3.99K	4.01K	3.93K	23.82K
Extraordinary Items	-	-	-	-	-	-	-
Change Receivables	-	-	-6.09K	-2.00K	-	-	-8.09K
Change To Inventory	-4.99K	-2.75K	-7.55K	-2.11K	-1.31K	-5.47K	-24.19K
Change To Liabilities	-	-	5.45K	4.24K	-954	1.13K	9.87K
Change To Net Income	-	-	12.15K	7.22K	-59.03K	-166.80K	-206.45K
ChangeToOperatingActivities	-	-	5.60K	874	-3.51K	1.16K	4.12K
Cash flows From Investing Activities	-	-	39.95K	-81.91K	15.59K	-5.87K	-32.24K
Capital Expenditures	-5.44K	-4.81K	-2.39K	-1.94K	-2.54K	-4.09K	-21.21K
Other Cashflows From Investing Activities	-	-	-	-	-	-	-
Cash From Financing Activities	123.32K	61.52K	6.33K	137.34K	25.24K	1.33K	355.08K
Net Borrowings	-	-	-145	14.87K	24.86K	-185	39.40K
Sale Purchase Of Stock	-	-1.42K	-643	121.93K	-	-	119.86K
Dividends Paid	-	-	643	-	-	-	643
Other Cashflows From Financing Activities	-	-4.28K	-1.38K	1.23K	379	1.51K	-2.53K
Cash And Cash Equivalents Changes	-	-	-12.57K	10.73K	-	-	-1.84K
Totals		72.11K	-37.70K	-82.23K	121.07K	-4.89K	-87.75K	-19.39K

Profile

Free Stocks

Company

Features

Contact Us